Diffuse fasciitis with eosinophilia in boys: a case-based review

Rheumatol Int. 2023 Sep;43(9):1755-1764. doi: 10.1007/s00296-023-05362-x. Epub 2023 Jun 14.

Abstract

Diffuse fasciitis with eosinophilia (EF) is a rare condition classified as a part of the connective tissue disorders. The clinical presentation of this condition can be diverse, however the main symptoms include symmetrical swelling and hardening of distal parts of limbs accompanied by peripheral eosinophilia. The diagnostic criteria are not specified. In inconclusions cases Magnetic Resonance Imaging (MRI) and skin to muscle biopsy may be useful. The pathogenesis and ethiology remain unknown, but extensive physical exertion, certain infectious factors, such as Borrelia burgdorferi, or medications may serve as a trigger. EF affects equally women and men, mainly in their middle age, however the disease can occur at any age. The standard therapy contents gluccocorticosteroids. As a second-line treatment, methotrexate is usually chosen. In this article we compare world reports of EF in paediatric patients with the cases of two adolescent male patients recently hospitalized in the Department of Paediatric Rheumatology.

Keywords: Clinical presentation of eosinophilic fasciitis; Diffuse fasciitis with eosinophilia; Eosinophilic fasciitis in children; Hypercalcemia.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Biopsy
  • Child
  • Eosinophilia* / complications
  • Fasciitis* / diagnostic imaging
  • Fasciitis* / drug therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Skin / pathology

Supplementary concepts

  • Eosinophilic Fasciitis